Communications Accepted for Short Oral

DUOFAG – Human Clinical Trial Phase I
Dana Štveráková, MB PHARMA s.r.o.,Czech Republic

Successful Eradication of Chronic Pseudomonas Aeruginosa Infection with Personalised Bacteriophage Therapy in Children with Cystic Fibrosis: An Early Phase Clinical Trial
Jagdev Singh, The Children’s Hospital at Westmead, Australia

Endolysin (Lysk04) Combined with Plant-Derived Phenylpropanoid Disrupt Outer Membrane Barriers and Exhibits Broad-Spectrum Antibacterial Activity Against High-Risk Gram-Negative Pathogens
Susweta Das, Dayananda Sagar University, India

Biohybrid Composites of Platelet-Rich Fibrin and Gelatin Hydrogel Beads (Nano/Micro) for Targeted Phage Delivery in the Treatment of Infected Wounds
Farzaneh Moghtader, TiPhage, Turkey

Anti-Quorum Sensing Phages Rescue Galleria mellonella Larvae from Pseudomonas aeruginosa Infection
Kira Céline Koonce, University of Copenhagen, Denmark

First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus Epidermidis Periprosthetic Joint Infection: An N-of-1 Trial
University of Ottawa at the Ottawa Hospital, Canada

Five years of adaptive phage therapy in the intensive care unit: Prospects, Limitations, Opportunities
Ekaterina A. Chernevskaya, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia

Freeze-Dried Tablets for Therapeutic Application of Bacteriophages
Marie Komárková, Masaryk University,Czech Republic

Novel Mycobacteriophages as a Promising Adjunct in the Fight Against Drug-Resistant TB and NTM Infections
Anthony Vocat, Lausanne University Hospital, Switzerland

Collateral Effects of Bacteriophage Resistance on Antibiotic Sensitivity in Pseudomonas Aeruginosa
Laura Rianne Baars, Leiden University, Netherland

Antibody Alternatives from Bacterial Viruses: Phage Receptor Binding Proteins as Novel Tools for Diagnostics and Therapy of Bacterial Infections
Peter Braun, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Germany

PHAGE–Postbiotic Synergy: a Novel Strategy against Pseudomonas Aeruginosa in Burn Wound Infection in Galleria Mellonella
Mine Egin, Karadeniz Technical University, Turkey

The Lausanne University Hospital GMP Production Pipeline for Manufacture of Therapeutic Bacteriophages
Gregory Resch, Lausanne University Hospital, Switzerland

A Multifaceted Experience with Phage Therapy: A Short Review of Successful and Challenging Cases across Multiple Body Systems
Mariam Dadiani, Eliava Phage Therapy Center, Georgia

 Phage P04 Loaded Polysaccharide Hydrogel to Combat Biofilm-Forming Klebsiella Pneumoniae Infected Lesions
Harshitha N, Dayananda Sagar University, India

Coevolution of Bacteriophages Enhances Biocontrol of Shiga Toxin-Producing Escherichia Coli in Food Matrix
Nicola Mangieri, University of Milan, Italy

Phage-Antibiotic Composite Efficacy on Dual-Species Biofilm
Tea Glonti, Queen Astrid Military Hospital, Belgium

Broad-Spectrum Lytic Bacteriophages from Wastewater as Therapeutic Candidates against Antibiotic-Resistant Clinical Strains
Erva Rakici, Recep Tayyip Erdogan University, Turkey

Isolation, Characterization and Anti-Biofilm Activity of Lytic Bacteriophage K2 against Klebsiella Pneumoniae Isolates
Damla Damar Celik, Marmara University, Turkey

From Biology to Business: INCATE as a Catalyst in the Antibacterial Innovation Pipeline
Mercedes Gonzalez Moreno, Hans KnöllInstitute (HKI), Germany

Cure of a Difficult-To-Treat Pseudomonas Aeruginosa Canine Chronic Otitis Externa (Oe) with the PyoBacteriophage Cocktail Followed by Antibiotics
Raphaël Baudin, Lausanne University Hospital (CHUV), Switzerland

AWMF Sk2 Guideline Personalized Bacteriophage Therapy in Germany
Simone Lieberknecht-Jouy, University Hospital Frankfurt, Germany

New Insights into Bacteriophage Therapy in Dogs
Eva Maria Kalbhenn, LABOKLIN GmbH & Co. KG, Germany

Source-Dependent Variability in Staphylococcus Aureus Susceptibility to Bacteriophage Infection
Hanife Nur Karakoc Parlayan, KaradenizTechnical University Trabzon, Turkey

Phage Heteroresistance in Clinical Klebsiella Pneumoniae Isolates: Impact of Differential Capsule Expression on Phage Efficacy
Iris Najjar, Escola Paulista deMedicina-Universidade Federal de São Paulo, Brazil

From Cells to Larvae: Two-Front Approach to Salmonella Eradication Using Bacteriophage Vb_Sen-Miriam1
Łukasz Grabowski, University of Gdansk, Poland

In Ovo Phage Administration as a Novel Prophylactic Approach against Salmonella Typhimurium in Broiler Chickens
Jan Torres-Boncompte, Centro de CalidadAvícola y Alimentación Animal de la Comunidad Valenciana (CECAV), Spain